Physician profile
Puneet Sethi
NPI 1275583395
$4,014.85
in general payments reported to CMS, 2019-2025
36 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $960 · 2020: $399 · 2021: $289 · 2022: $1,344 · 2023: $631 · 2024: $60.81 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.13 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $675.97 | 2022-2025 | Inspire |
| Ethicon INC. | $594.11 | 2022-2025 | Monarch Platform |
| Mallinckrodt Hospital Products INC. | $421.32 | 2022-2023 | Acthar |
| Actelion Pharmaceuticals US, INC. | $307.51 | 2019-2022 | |
| Glaxosmithkline, LLC. | $244.30 | 2019-2024 | Nucala |
| Janssen Pharmaceuticals, INC | $190.83 | 2019-2021 | |
| Galvanize Therapeutics, INC | $159.63 | 2025 | Aliya System |
| Sunovion Pharmaceuticals INC. | $152.15 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $151.30 | 2019-2023 | Tezspire |
| Mylan Specialty L.P. | $122.55 | 2019-2021 | |
| Grifols USA, LLC | $122.02 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $115.61 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $98.89 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.07 | 2019-2022 | |
| Philips North America LLC | $63.23 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $62.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.83 | 2022 | |
| Baxter Healthcare | $53.20 | 2022 | |
| Genzyme Corporation | $39.87 | 2019-2022 | |
| Vapotherm INC | $32.03 | 2022 | |
| Merck Sharp & Dohme LLC | $31.15 | 2021 | |
| Harmony Biosciences LLC | $28.18 | 2022 | |
| Shionogi INC | $17.79 | 2022 | |
| Mayne Pharma Commercial LLC | $17.45 | 2020 | |
| Itamar Medical INC | $16.99 | 2022 | |
| Chiesi USA, INC. | $16.56 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.51 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.06 | 2021 | |
| Verona Pharma, INC. | $15.70 | 2025 | Ohtuvayre |
| Electromed, INC. | $15.42 | 2023 | Smartvest |
| Nabriva Therapeutics, Plc | $14.64 | 2020 | |
| Shire North American Group INC | $13.74 | 2019 | |
| Amgen INC. | $13.05 | 2022 | |
| Insmed, INC. | $12.86 | 2020 | |
| Breathe Technologies, INC. | $12.48 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puneet Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.